Increasing the intensity of illumination degrades the efficacy of regular CXL, but it doesn’t seem to with PACK-CXL. Why?

Commodity parts, powerful processors and clever algorithms are changing ophthalmology – cheaply.

Here we recognize a year’s worth of innovation. Apps, IOLs, vitreous cutters, imagers and lasers – the latest and greatest of these are all there.

Peek Retina is an adaptor for your smartphone that promises easy and high-quality fundoscopy – no matter if you’re in Scotland or sub-Saharan Africa

It’s a reasonable – and until now – unanswered question: which eye is the one that tells the brain where a target lies?

Poor power, false positives and false negatives crucify the credibility of p<0.05

Raised risk of central serous chorioretinopathy associated with Androgel or Testopill treatment

What does analysis of the last five years of literature on branch retinal vein occlusion tell us about the priorities of the field and the major contributors to it?

Regeneron released preliminary data of the DRCR.net Protocol T trial. The DRCR.net hasn‘t, and won’t for a while.

Sitting Down With… John Kanellopoulos Clinical Professor of Ophthalmology, New York University Medical School, Partner at OMMA Eye Institute, and Founder and Scientific Manager of Laservision.gr Institute, Athens, Greece